A New Non-Hormonal Drug to Treat Menopausal Hot Flashes
The U.S. Food and Drug Administration (FDA) has officially approved a new prescription medication called Veozah to treat hot flashes in menopausal women.
This is a big step forward — especially for women who can’t or don’t want to take hormone-based treatments.
What Is Veozah?
Veozah (fezolinetant) is the first non-hormonal medication specifically designed to treat moderate to severe hot flashes caused by menopause.
It works differently from hormone replacement therapy (HRT) by targeting the part of the brain that regulates body temperature — helping reduce sudden heat and sweating episodes.
Why It Matters
Hot flashes and night sweats are two of the most common symptoms of menopause. They can:
- Disrupt sleep
- Affect daily life and work
- Increase anxiety and discomfort
While hormone therapy has helped many women, it’s not suitable for everyone — especially those with a history of breast cancer, blood clots, or heart conditions. Veozah now offers a non-hormonal option for relief.
How Veozah Works
Veozah blocks a protein in the brain called NK3R (neurokinin 3 receptor), which is believed to overreact when estrogen levels drop during menopause.
By calming this signal, Veozah helps regulate the body’s temperature control system — reducing both daytime hot flashes and night sweats.
Who Can Use Veozah?
- Postmenopausal women with moderate to severe vasomotor symptoms (hot flashes and night sweats)
- Women who can’t take estrogen or prefer not to use hormone therapy
- However, like all medications, Veozah may not be suitable for everyone. Doctors will assess medical history before prescribing it.
Are There Side Effects?
Some women in clinical trials reported mild side effects such as:
- Headaches
- Stomach pain
- Elevated liver enzymes
Because of this, liver function may need to be monitored while using the drug.
Final Thought
The approval of Veozah gives women a new and much-needed option for hot flash relief without hormones. It’s a sign that menopause care is finally advancing, offering more choices based on individual needs.
If you’re struggling with hot flashes and want an alternative to hormone therapy, talk to your doctor about whether Veozah could be right for you.
Full Credit to: Can This FDA-Approved Drug Tame Hot Flashes and Menopause Belly? [Yahoo]
FemTalkAsia Takeaways
- Veozah Offers a Non-Hormonal Option: For women who can’t or don’t want to use hormone therapy, Veozah is the first FDA-approved non-hormonal drug for treating hot flashes.
- It Targets the Brain, Not Hormones: Veozah works by calming the brain’s temperature control system through the NK3R pathway — offering relief without using estrogen.
- Hot Flash Relief for More Women: This is a major step forward for women with a history of breast cancer, blood clots, or other conditions that make hormone therapy unsafe.
- Mild Side Effects Are Possible: Some women in trials experienced headaches or mild digestive issues, and liver function monitoring may be recommended.
- More Choices Mean Better Menopause Care: The approval of Veozah reflects a growing focus on menopause care and gives women more personalized treatment options.
Discover more from FemTalkAsia
Subscribe to get the latest posts sent to your email.
